ArticleCancer management and research2020

Depth of Response and Early Tumor Shrinkage for Predicting Clinical Outcomes in HER2-Positive Metastatic Breast Cancer Treated with Trastuzumab.

Yi-Qun Che et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.